Other Clinical Trial - Atlas of Intracranial Recordings on Cortical

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04997226` - Cognitive Enhancement in Healthy Elderly People	N/A
Recruiting	`NCT05502822` - High Definition Transcranial Alternating Current Stimulation (HD-tACS) for Post-stroke Aphasia	N/A
Not yet recruiting	`NCT05312359` - Brain Mechanism and Intervention of Executive-control Dysfunction Among Substance Dependents	N/A
Completed	`NCT05809076` - Effects of Gamma-tACS on EEG Periodic Activity	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT04997226 - Cognitive Enhancement in Healthy Elderly People

N/A

Recruiting

NCT05502822 - High Definition Transcranial Alternating Current Stimulation (HD-tACS) for Post-stroke Aphasia

N/A

Not yet recruiting

NCT05312359 - Brain Mechanism and Intervention of Executive-control Dysfunction Among Substance Dependents

N/A

Completed

NCT05809076 - Effects of Gamma-tACS on EEG Periodic Activity

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04560959
Study type	Interventional
Source	Xuanwu Hospital, Beijing
Contact	P.H. Wei
Phone	+86-010-83198252
Email	weipenghu@xwhosp.org
Status	Not yet recruiting
Phase	Phase 1/Phase 2
Start date	September 20, 2020
Completion date	December 1, 2021

Atlas of Intracranial Recordings on Cortical Responses After Functional tACS — AIRCRAFT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms